Crossmark

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

Published Online: 2021-04-16

Published Print: 2021-05

Authors

Alsumali, Adnan

Lautsch, Dominik

Liu, Rongzhe

Patel, Dipen

Nanji, Sakina

Djatche, Laurence M.
Funding

Funding for this research was provided by:

Merck
License Information

Text and Data Mining valid from 2021-04-16

Version of Record valid from 2021-04-16
More Information

Article History

Received: 28 January 2021

Accepted: 19 February 2021

First Online: 16 April 2021

Document is current